Icosavax Inc (ICVX)

NASDAQ
15.73
+0.06(+0.38%)
  • Volume:
    264
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    15.73 - 15.73

ICVX Overview

Prev. Close
15.67
Day's Range
15.73-15.73
Revenue
7.35M
Open
15.73
52 wk Range
14.91-49.99
EPS
-
Volume
264
Market Cap
611.79M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
95,674
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
39,041,805
Next Earnings Date
Mar. 02, 2022
What is your sentiment on Icosavax Inc?
or
Vote to see community's results!

  • Icosavax outlines anticipated milestones for 2022
    • BySeeking Alpha-

    Icosavax (ICVX) provides a corporate update and shared anticipated milestones for 2022. Expanded Seattle headquarters. The company recently signed a lease on a new facility of...

Icosavax Inc Company Profile

Employees
22

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-A12, an respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-121, a vaccine candidate with RSV target; IVX-241, a vaccine candidate with hMPV target; IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2^ target indication; and IVX-421, a variant RBD antigen with SARS-CoV-2^ target indication. The company was incorporated in 2017 and is headquartered in Seattle, Washington.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellSell
SummaryStrong SellStrong SellStrong SellStrong SellSell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.